BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 29340875)

  • 21. Validation of Nafamostat Mesilate as an Anticoagulant in Extracorporeal Membrane Oxygenation: A Large-Animal Experiment.
    Han SJ; Han W; Song HJ; Kim CS; Jeong SM; Kang MW
    Korean J Thorac Cardiovasc Surg; 2018 Apr; 51(2):114-121. PubMed ID: 29662809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Comparison of Activated Partial Thromboplastin Time and Activated Coagulation Time for Anticoagulation Monitoring during Extracorporeal Membrane Oxygenation Therapy.
    Liu Y; Yuan Z; Han X; Song K; Xing J
    Hamostaseologie; 2023 Jun; 43(3):171-178. PubMed ID: 35882351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Coagulation Parameters, Anticoagulation, and Need for Transfusion in Patients on Interventional Lung Assist or Veno-Venous Extracorporeal Membrane Oxygenation.
    Weingart C; Lubnow M; Philipp A; Bein T; Camboni D; Müller T
    Artif Organs; 2015 Sep; 39(9):765-73. PubMed ID: 25921195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Initial Anticoagulation Targets on Bleeding and Thrombotic Complications for Patients With Acute Respiratory Distress Syndrome Receiving Extracorporeal Membrane Oxygenation.
    Cercone JL; Kram SJ; Trammel MA; Rackley CR; Lee HJ; Merchant J; Kram BL
    J Cardiothorac Vasc Anesth; 2022 Sep; 36(9):3561-3569. PubMed ID: 35691853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced anticoagulation targets in extracorporeal life support (RATE): study protocol for a randomized controlled trial.
    van Minnen O; Oude Lansink-Hartgring A; van den Boogaard B; van den Brule J; Bulpa P; Bunge JJH; Delnoij TSR; Elzo Kraemer CV; Kuijpers M; Lambermont B; Maas JJ; de Metz J; Michaux I; van de Pol I; van de Poll M; Raasveld SJ; Raes M; Dos Reis Miranda D; Scholten E; Simonet O; Taccone FS; Vallot F; Vlaar APJ; van den Bergh WM
    Trials; 2022 May; 23(1):405. PubMed ID: 35578271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heparin-free after 3000 IU heparin loaded in veno-venous ECMO supported acute respiratory failure patients with hemorrhage risk: a novel anti-coagulation strategy.
    Zhao YC; Zhao X; Fu GW; Huang MJ; Li XX; Sun QQ; Kan YB; Li J; Wang SL; Ma WT; Xu QF; Liu QL; Li HB
    Thromb J; 2022 Jun; 20(1):36. PubMed ID: 35761333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of thromboelastography in children on extracorporeal membrane oxygenation.
    Wagner ML; Johnston M; Jenkins T; Palumbo JS; Rymeski BA
    J Pediatr Surg; 2022 Jun; 57(6):1056-1061. PubMed ID: 35304022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pilot study evaluating a non-titrating, weight-based anticoagulation scheme for patients on veno-venous extracorporeal membrane oxygenation.
    Deatrick KB; Galvagno SM; Mazzeffi MA; Kaczoroswki DJ; Herr DL; Rector R; Hochberg E; Rabinowitz RP; Scalea TM; Menaker J
    Perfusion; 2020 Jan; 35(1):13-18. PubMed ID: 31122144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measures of anticoagulation and coagulopathy in pediatric cardiac extracorporeal membrane oxygenation patients.
    Yabrodi M; Ciccotello C; Bhatia AK; Davis J; Maher KO; Deshpande SR
    Int J Artif Organs; 2022 Jan; 45(1):60-67. PubMed ID: 33372565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. aPTT-guided anticoagulation monitoring during ECMO support: A systematic review and meta-analysis.
    Rajsic S; Treml B; Jadzic D; Breitkopf R; Oberleitner C; Bachler M; Bösch J; Bukumiric Z
    J Crit Care; 2023 Oct; 77():154332. PubMed ID: 37244207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Venovenous Extracorporeal Membrane Oxygenation With Prophylactic Subcutaneous Anticoagulation Only: An Observational Study in More Than 60 Patients.
    Krueger K; Schmutz A; Zieger B; Kalbhenn J
    Artif Organs; 2017 Feb; 41(2):186-192. PubMed ID: 27256966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Poor Reliability of Common Measures of Anticoagulation in Pediatric Extracorporeal Membrane Oxygenation.
    Rabinowitz EJ; Ouyang A; Armstrong DR; Wallendorf M; Said AS
    ASAIO J; 2022 Jun; 68(6):850-858. PubMed ID: 34581287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the activated clotting time and activated partial thromboplastin time for the monitoring of heparin in adult extracorporeal membrane oxygenation patients.
    Atallah S; Liebl M; Fitousis K; Bostan F; Masud F
    Perfusion; 2014 Sep; 29(5):456-61. PubMed ID: 24570077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of argatroban in patients with acute respiratory distress syndrome and extracorporeal lung support.
    Menk M; Briem P; Weiss B; Gassner M; Schwaiberger D; Goldmann A; Pille C; Weber-Carstens S
    Ann Intensive Care; 2017 Dec; 7(1):82. PubMed ID: 28776204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemorrhage under veno-venous extracorporeal membrane oxygenation in acute respiratory distress syndrome patients: a retrospective data analysis.
    Kreyer S; Muders T; Theuerkauf N; Spitzhüttl J; Schellhaas T; Schewe JC; Guenther U; Wrigge H; Putensen C
    J Thorac Dis; 2017 Dec; 9(12):5017-5029. PubMed ID: 29312706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Anti-Xa and Activated Partial Thromboplastin Time Monitoring of Heparin in Adult Patients Receiving Extracorporeal Membrane Oxygenation Support.
    Arnouk S; Altshuler D; Lewis TC; Merchan C; Smith DE; Toy B; Zakhary B; Papadopoulos J
    ASAIO J; 2020 Mar; 66(3):300-306. PubMed ID: 31045921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of aPTT-Guided Anticoagulation Monitoring with Thromboembolic Events in Patients Receiving V-A ECMO Support: A Systematic Review and Meta-Analysis.
    Rajsic S; Breitkopf R; Treml B; Jadzic D; Oberleitner C; Oezpeker UC; Innerhofer N; Bukumiric Z
    J Clin Med; 2023 Apr; 12(9):. PubMed ID: 37176673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new anticoagulation strategy using recombinant human thrombomodulin in patients on veno-venous extracorporeal membrane oxygenation: a retrospective study.
    Yasuda N; Goto K; Mizoguchi T; Ohchi Y; Nureki SI; Kitano T
    Ann Palliat Med; 2021 Feb; 10(2):1834-1841. PubMed ID: 33440963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of anticoagulation monitoring strategies for adults supported on extracorporeal membrane oxygenation: A systematic review.
    Sun J; Ma Y; Su W; Miao H; Guo Z; Chen Q; Zhang Y; Ma X; Chen S; Ding R
    Heart Lung; 2023; 61():72-83. PubMed ID: 37167901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antithrombin during veno-venous extracorporeal membrane oxygenation with heparin anticoagulation: A single-center cohort study.
    Hileman BA; Martucci G; Rizzitello N; Occhipinti G; Rossetti M; Tuzzolino F; Lorusso R; Panigada M; Tanaka K; Arcadipane A; Panarello G
    Perfusion; 2024 Jun; ():2676591241258048. PubMed ID: 38833217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.